Review article · 2019 · Open access
Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments
Frontiers in Pharmacology, 10, 695 · Published 20 June 2019 · DOI 10.3389/fphar.2019.00695
In brief
“Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments” is a 2019 review article by Susanna Cordone and 3 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 153 citations as of 20 November 2026, which puts it in the top 5% of works published in 2019 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.
- Citations
- 153
- Most cited in
- 2024 (29)
- Field-weighted impact
- 1.79
- References
- 117
- Authors
- 4
Abstract
The growing interest in the preclinical stage of Alzheimer's disease (AD) led investigators to identify modifiable risk and predictive factors useful to design early intervention strategies. The preclinical stage of AD is characterized by β-amyloid (Aβ) aggregation into amyloid plaques and tau phosphorylation and aggregation into neurofibrillary tangles. There is a consensus on the importance of sleep within this context: the bidirectional relationship between sleep and AD pathology is supported by growing evidence that proved that the occurrence of sleep changes starting from the preclinical stage of AD, many years before the onset of cognitive decline. Hence, we review the most recent studies on sleep disturbances related to Aβ and the effects of sleep deprivation on Aβ accumulation in animal and human models. We also discuss evidence on the role of sleep in clearing the brain of toxic metabolic by-products, with original findings of the clearance activity of the glymphatic system stimulated by sleep. Furthermore, starting from new recent advances about the relationship between slow-wave sleep (SWS) and Aβ burden, we review the results of recent electroencephalographic (EEG) studies in order to clarify the possible role of SWS component disruption as a novel mechanistic pathway through which Aβ pathology may contribute to cognitive decline and, conversely, the eventual useful role of SWS in facilitating Aβ clearance. Finally, we discuss some promising innovative, effective, low-risk, non-invasive interventions, although empirical evidence on the efficacy of sleep interventions in improving the course of AD is at the very beginning.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Cordone, S., Annarumma, L., Rossini, P. M., & De Gennaro, L. (2019). Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments. Frontiers in Pharmacology, 10, 695. https://doi.org/10.3389/fphar.2019.00695
MLA 9
Cordone, Susanna, et al. “Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments.” Frontiers in Pharmacology, vol. 10, 2019, p. 695. https://doi.org/10.3389/fphar.2019.00695.
Chicago
Cordone, Susanna, Ludovica Annarumma, Paolo Maria Rossini, and Luigi De Gennaro. 2019. “Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments.” Frontiers in Pharmacology 10: 695. https://doi.org/10.3389/fphar.2019.00695.
Harvard
Cordone, S. et al. (2019) ‘Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments’, Frontiers in Pharmacology, 10, p. 695. doi:10.3389/fphar.2019.00695.
IEEE
S. Cordone, L. Annarumma, P. M. Rossini, and L. De Gennaro, “Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments,” Frontiers in Pharmacology, vol. 10, p. 695, 2019, doi: 10.3389/fphar.2019.00695.
BibTeX
@article{cordone2019sleep,
title = {{Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments}},
author = {Cordone, Susanna and Annarumma, Ludovica and Rossini, Paolo Maria and De Gennaro, Luigi},
journal = {Frontiers in Pharmacology},
year = {2019},
volume = {10},
pages = {695},
doi = {10.3389/fphar.2019.00695},
url = {https://doi.org/10.3389/fphar.2019.00695}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 3 | |
| 2020 | 21 | |
| 2021 | 27 | |
| 2022 | 23 | |
| 2023 | 16 | |
| 2024 | 29 | |
| 2025 | 21 | |
| 2026 | 13 |
Its field-weighted citation impact is 1.79: it has been cited 1.79 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- sleep
- amyloid-beta deposition
- amyloid plaques
- preclinical Alzheimer's disease
- sleep disorders
- sleep deprivation
- glymphatic system
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Cordone, S., Annarumma, L., Rossini, P. M., & De Gennaro, L. (2019). Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments. Frontiers in Pharmacology, 10, 695. https://doi.org/10.3389/fphar.2019.00695
How many times has this paper been cited?
153 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.
Who wrote this paper?
Susanna Cordone, Ludovica Annarumma, Paolo Maria Rossini, Luigi De Gennaro.
What is the DOI of this paper?
10.3389/fphar.2019.00695, permanently at https://doi.org/10.3389/fphar.2019.00695. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.